Global Biotech ETF
(ASX:CURE}

(ASX:CURE}
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
We’ve closed several high-conviction trades.
Aurizon Holdings is rated a buy with the stop loss at $2.95
Amcor is rated a buy with the stop loss at $14.15
The number of holdings has been reduced as the uptrend, or market bounce, matures.
Or start a free thirty day trial for our full service, which includes our ASX Research.